Nov 18, 2020   SOURCE: BusinessWire

Worldwide Hepatitis B Vaccines Industry to 2024 - Key Drivers, Challenges and Trends - ResearchAndMarkets.com

The "Global Hepatitis B Vaccines Market 2020-2024" report has been added to ResearchAndMarkets.com's offering.

The hepatitis b vaccines market is poised to grow by $ 524.00 million during 2020-2024, progressing at a CAGR of 4% during the forecast period.

The report on the hepatitis B vaccines market provide a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the high prevalence of hepatitis B globally, rising initiatives to increase awareness about hepatitis B, and increasing funding for the development of vaccines.

The hepatitis B vaccines market analysis includes end-user segment, type segment, and geographical landscapes. This study identifies the rising awareness of immunization in low- and middle-income countries as one of the prime reasons driving the hepatitis B vaccine market growth during the next few years. Also, new technological advancements and a strong pipeline will lead to sizable demand in the market.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.

Companies Mentioned

  • Bharat Biotech Ltd.
  • Dynavax Technologies Corp.
  • GlaxoSmithKline Plc
  • Indian Immunologicals Ltd.
  • KM Biologics Co. Ltd.
  • LG Chem Ltd.
  • Merck & Co. Inc.
  • Sanofi
  • Serum Institute of India Pvt. Ltd.
  • Shenzhen Kangtai Biological Products Co. Ltd.

The report on the hepatitis b vaccines market covers the following areas:

  • Hepatitis b vaccines market sizing
  • Hepatitis b vaccines market forecast
  • Hepatitis b vaccines market industry analysis

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary.

This market research report provides a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Key Topics Covered:

1. Executive Summary

  • Market Overview

2. Market Landscape

  • Market ecosystem
  • Value chain analysis

3. Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024

4. Five Forces Analysis

  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

5. Market Segmentation by End-user

  • Market segments
  • Comparison by End-user
  • Adult - Market size and forecast 2019-2024
  • Pediatric - Market size and forecast 2019-2024
  • Market opportunity by End-user

6. Market Segmentation by Type

  • Mono vaccines
  • Combination vaccines

7. Customer landscape

  • Overview

8. Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends

9. Vendor Landscape

  • Overview
  • Landscape disruption

10. Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • Bharat Biotech Ltd.
  • Dynavax Technologies Corp.
  • GlaxoSmithKline Plc
  • Indian Immunologicals Ltd.
  • KM Biologics Co. Ltd.
  • LG Chem Ltd.
  • Merck & Co. Inc.
  • Sanofi
  • Serum Institute of India Pvt. Ltd.
  • Shenzhen Kangtai Biological Products Co. Ltd.

11. Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

For more information about this report visit https://www.researchandmarkets.com/r/jecaos